Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 11:28 am Purchase | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 70,995 7.500% | 16,954 (+31.37%) | Filing History |
| 2023-02-13 8:14 pm Purchase | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 96,176 9.990% | 3,593 (+3.88%) | Filing History |
| 2023-02-10 4:20 pm Unchanged | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | SEATTLE GENETICS INC SGEN | 46,327 5.000% | 0 (Unchanged) | Filing History |
| 2023-02-10 10:22 am Unchanged | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ASTRAZENECA PLC | 44,803 4.800% | 0 (Unchanged) | Filing History |
| 2023-01-27 5:02 pm Purchase | 2023-01-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 50,000 5.400% | 37,500 (+300.00%) | Filing History |
| 2023-01-26 5:01 pm Sale | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 12,500 1.300% | -36,061 (-74.26%) | Filing History |
| 2022-10-24 4:57 pm Purchase | 2022-10-13 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Lynx1 Capital Management LP | 47,808 5.100% | 47,808 (New Position) | Filing History |
| 2022-02-14 3:20 pm Sale | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 54,041 5.900% | -5,988 (-9.97%) | Filing History |
| 2022-02-14 1:56 pm Purchase | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 92,583 9.990% | 22,563 (+32.22%) | Filing History |
| 2022-02-14 06:22 am Sale | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | CITADEL ADVISORS LLC | 40,760 4.500% | -775 (-1.87%) | Filing History |
| 2022-02-14 06:08 am Unchanged | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Nussbaum Ran | 44,643 4.960% | 0 (Unchanged) | Filing History |
| 2022-01-27 4:30 pm Purchase | 2022-01-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Soleus Capital Master Fund, L.P. | 48,561 5.400% | 48,561 (New Position) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BlackRock Inc. BLK | 16,281 2.100% | -29,111 (-64.13%) | Filing History |
| 2021-07-06 4:03 pm Purchase | 2021-06-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS | CITADEL ADVISORS LLC | 41,536 5.200% | 41,536 (New Position) | Filing History |
| 2021-04-07 5:37 pm Purchase | 2021-04-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ASTRAZENECA PLC | 44,803 5.660% | 44,803 (New Position) | Filing History |
| 2021-04-02 4:20 pm Purchase | 2021-03-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | SEATTLE GENETICS INC SGEN | 46,327 6.200% | 46,327 (New Position) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital Management LLC | 60,029 8.400% | -9,665 (-13.87%) | Filing History |
| 2021-02-16 07:31 am Purchase | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Nussbaum Ran | 44,643 6.400% | 44,643 (New Position) | Filing History |
| 2021-02-12 4:20 pm Sale | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 70,020 9.990% | -3,390 (-4.62%) | Filing History |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BlackRock Inc. BLK | 45,391 6.500% | 2,827 (+6.64%) | Filing History |